Skip to content

Normogram of Umbilical Artery and Fetal Middle Cerebral Artery Doppler Indices in Upper Egyptian Women

Normogram of Umbilical Artery and Fetal Middle Cerebral Artery Doppler Indices in Upper Egyptian Women

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06761794
Enrollment
520
Registered
2025-01-07
Start date
2025-01-31
Completion date
2026-04-30
Last updated
2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Doppler in Normal Pregnancy

Brief summary

settle umbilical and fetal middle cerebral arteries Doppler indices( pulsatility index and resistive index) in normal pregnancy to generate a local reference range and calculate cerebroplacental ratio.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

1. Singleton pregnancy between 15 and 40 weeks gestational age. 2. Sure of her date (well-known LMP or confirmed date by an early ultrasound). 3. Normal fetal anatomy. 4. No history of medical disorders.

Exclusion criteria

1. Multiple pregnancy 2. Fetal anomalies. 3. Associated medical disorders. 4. Obstetric complications.

Design outcomes

Primary

MeasureTime frame
pulsatility index of umbilical artery.Through study completion, an average of 1 year
Resistive index of umbilical arteryThrough study completion, an average of 1 year
pulsatility index of fetal middle cerebral artery.Through study completion, an average of 1 year
Resistive index of fetal middle cerebral arteryThrough study completion, an average of 1 year

Secondary

MeasureTime frame
settle cerebroplacental ratio local reference range.Through study completion, an average of 1 year

Contacts

Primary ContactSalma Kamel Bakhit, Graduate
salma0122858@gmail.com0201094242196

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026